One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papers
Open Accesshttps://doi.org/10.1182/blood-2021-146507
Copy DOI Journal: Blood |  Publication Date: Nov 5, 2021 |
 Citations: 1 |
Affiliation: Memorial Sloan Kettering Cancer Center, The University of Texas MD Anderson Cancer Center, UCLA Medical Center, City Of Hope National Medical Center, Dana-Farber Cancer Institute, Hackensack University Medical Center, Massachusetts General Hospital, Agios Pharmaceuticals (United States), Erasmus MC, Vanderbilt University Medical Center, Bristol-Myers Squibb (United States), The Ohio State University Wexner Medical Center, The University of Texas Southwestern Medical Center, University Hospital Ulm, University of Chicago, Bristol-Myers Squibb (Switzerland), University of Colorado DenverUpdated Survival and Response Analyses from a Phase 1 Study of Ivosidenib or Enasidenib Combined with Induction and Consolidation Chemotherapy in Patients with Newly Diagnosed AML with an IDH1 or IDH2 Mutation
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
